United Therapeutics Corporation To Present At The 10th Annual J.P. Morgan Napa Valley Forum
United Therapeutics Corporation (Nasdaq: UTHR) announced that Dr. Gil Golden, Executive Vice President and Chief Medical Officer, will present an overview of the company during a virtual session at the 10th Annual J.P. Morgan Napa Valley Forum on March 31, 2021. The presentation is scheduled from 12:00 p.m. to 12:45 p.m. EDT and will be accessible via a live webcast on the company's website. An archived version will be available for 30 days post-event. United Therapeutics focuses on innovative biotechnology and aims to address organ shortages through its subsidiary, Lung Biotechnology PBC.
- None.
- None.
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 24, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Gil Golden, Executive Vice President and Chief Medical Officer of United Therapeutics, will provide an overview and update on the company's business during a fireside chat session at the 10th Annual J.P. Morgan Napa Valley Forum.
The session will take place virtually on Wednesday, March 31, 2021, from 12:00 p.m. to 12:45 p.m., Eastern Daylight Time, and can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed at the same location for 30 days.
About United Therapeutics
United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture, and our bioinformatics leadership. We also believe that our determination to be responsible citizens – having a positive impact on patients, the environment, and society – will sustain our success in the long term.
Through our wholly owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Forward-looking Statements
Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements relating to our ability to create value and sustain our success in the long-term, as well as our efforts to develop technologies that either delay the need for transplantable organs or expand the supply of transplantable organs. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of March 24, 2021 and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events, or any other reason.
For Further Information Contact:
Dewey Steadman at (202) 919-4097
Email: ir@unither.com
View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-present-at-the-10th-annual-jp-morgan-napa-valley-forum-301254427.html
SOURCE United Therapeutics Corporation
FAQ
What is United Therapeutics Corporation's stock symbol?
When will United Therapeutics present at the J.P. Morgan Napa Valley Forum?
Who will speak for United Therapeutics at the forum?
How can I access the United Therapeutics presentation?
Will the presentation be available after the live event?
